Apart from the most scrutinized mutations in EGFR, some researchers are focused on the development of ddPCR assays for less common mutations, such as G719S and L851Q, in advanced NSCLC patients [44]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.